JUN and atherosclerosis: We speculate that the increase in local and circulating IL-33 levels in patients with atherosclerotic and/or inflammatory diseases would stimulate the vascular endothelial cells to enhance IL-8 production via JNK-c-Jun-AP-1 pathway, contributing to the development of inflammatory disorders including atherosclerosis.